TPTX - Turning Point Therapeutics GAAP EPS of -$1.50 beats by $0.01 revenue of $0.43M May, 10 2022 04:33 PM Turning Point Therapeutics Inc. Turning Point Therapeutics press release (NASDAQ:TPTX): Q1 GAAP EPS of -$1.50 beats by $0.01. Revenue of $0.43M (-98.3% Y/Y). For further details see: Turning Point Therapeutics GAAP EPS of -$1.50 beats by $0.01, revenue of $0.43M